Pharma and Biotech
£150,000 Convertible Loan Note Issue | 20-May-2025 | 07:00 | RNS |
Final results for the year ended 31 December 2024 | 30-Apr-2025 | 11:18 | RNS |
Contract in Caribbean and Update on CIZ1B | 28-Apr-2025 | 07:00 | RNS |
Appointment of Non-Executive Director | 25-Mar-2025 | 07:00 | RNS |
Update on Launch of CIZ1B Biomarker Assay | 24-Mar-2025 | 07:00 | RNS |
Appointment of Professor Dawn Coverley as CSO | 02-Jan-2025 | 07:00 | RNS |
Update on Strategic Partnership in North America | 16-Dec-2024 | 07:00 | RNS |
Execution of Agreement for North America | 21-Oct-2024 | 07:00 | RNS |
Update on Licensing and Partnership Agreement | 03-Oct-2024 | 13:12 | RNS |
Interim Results | 30-Sep-2024 | 07:00 | RNS |
Holding(s) in Company | 16-Sep-2024 | 07:00 | RNS |
Collaboration with Moffitt Cancer Center | 09-Sep-2024 | 07:00 | RNS |
Update on Strategic Partnership in North America | 25-Jul-2024 | 07:00 | RNS |
Manufacturing Agreement with BBI Solutions | 18-Jul-2024 | 07:00 | RNS |
Issue of Share Options in Lieu of Consultancy Fees | 09-Jul-2024 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 1.85p |
Change Today | 0.20p |
% Change | 12.12 % |
52 Week High | 2.30 |
52 Week Low | 1.40 |
Volume | 4,280,018 |
Shares Issued | 396.39m |
Market Cap | £7.33m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:24 | 1,000,000 @ 1.70p |
16:26 | 15,000 @ 1.89p |
16:00 | 15,876 @ 1.85p |
12:40 | 100,000 @ 1.89p |
12:13 | 75,000 @ 1.89p |
Finance Director | Nigel Ronald Lee |
You are here: research